Not logged inOptimizing oncology drug development: systematic review of 22 years of myeloma randomized controlled trials
Maria Mainou, MD; Muatassem Alsadhan, MD; Kalliopi Tsapa, MD; Alissa Visram, MD; Hira Mian, MD; Rakesh Popat, MD; Elias K Mai, MD; Rajshekhar Chakraborty, MD; Samer Al Hadidi, MD; Meera Mohan, MD; Aniko Szabo, PhD; Oliver Van Oekelen, MD; Edward R Scheffer Cliff, MBBS; Ghulam Rehman Mohyuddin, MD .png)
Share.png)
Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
